Breast Cancer Screening Using AI-Assisted Single Radiologist Reading Compared to Standard Double Radiologist Reading
Led by University Hospital Olomouc · Updated on 2026-04-02
8000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of artificial intelligence AI to assist in interpreting mammography images for breast cancer screening. The study compares a new approach where a single radiologist reads mammograms with AI support against the current standard of having two radiologists independently read the images without AI. This research aims to understand how AI might affect the quality of breast cancer screening programs.
Participants are randomly assigned to one of two groups based on specific days. In the intervention group, one radiologist reviews the mammogram images with AI assistance, followed by a standard second reading by another radiologist to meet legal double-reading requirements. In the control group, two radiologists independently read the mammograms without AI support, following current standard practice.
Participants are asymptomatic women aged 45 to 69 years who take part in a breast cancer screening program. The study measures outcomes such as the rate of further assessments needed within 190 days after screening, cancer detection rates up to one year after screening, and recall rates within 190 days. The study is set to start in October 2025 and will monitor these outcomes to assess the impact of AI support in mammogram reading.
CONDITIONS
Brief Title
Screening Mammography: Single Reading by One Radiologist With AI vs. Double Reading by Two Radiologists (AI-BCSQ)
Research Team
L
Lucia Veverkova, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Asymptomatic women participating in a breast cancer screening program
You will not qualify if you...
Presence of clinical signs of breast disease requiring diagnostic mammography
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - 1 day
Participants undergo screening mammography which is read either by one radiologist with AI support followed by a second radiologist reading, or by two radiologists without AI support according to randomization assignment.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 1 year
Participants are monitored for outcomes such as further assessment, cancer detection, and recall up to one year after the screening mammography.
Follow-up assessments as per standard screening program
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Using AI-Enabled Electrocardiogram to Detect Pulmonary Hypertension in Adults Aged 50 to 85 A Randomized Controlled Trial
Multi-center Study Evaluating AI Accuracy in Echocardiography for Heart Disease Diagnosis and Treatment
Comparing AI and Physician Measurements Across Various Heart Conditions
Study Evaluating Real-time AI System EndoAIM for Measuring Colorectal Polyp Size During Colonoscopy
Randomized Study of AI-Assisted vs Standard Screening Mammography
for Breast Cancer Detection and Recall in Adults
Study of an AI Model to Evaluate Cardiac Surgeons Techniques During Coronary Artery Bypass Grafting
Study of AI Software for Detecting and Predicting Stability of Unruptured Cerebral Aneurysms Using Non-Invasive Imaging
Evaluating How Timing of AI Support Affects Chest X-ray Interpretation by Healthcare Professionals Using Eye-Tracking
AI-Assisted Analgesia Copilot System to Improve Pain Management During General Anesthesia in Elective Surgeries
Development and Evaluation of an AI-Assisted Nursing Care Robot to Reduce Nurse Workload and Improve Care Quality
Evaluating AI-Assisted Digital Management to Improve Medication Safety and Reduce Healthcare Burden in Advanced Solid Tumors A Controlled Real-World Study
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study.
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.